Who Paid My Doc
Frederic Moll
General Practice Redwood City, CA Medical Doctor
NPI 1306286851 CMS profile 286115
275 Shoreline Dr Ste 100, Redwood City, CA 94065
General payments
$2,548,209
Research payments
$0
Ownership & investment interest
$114,436,262
Through program year 2025, Frederic Moll of Redwood City, CA is reported in the CMS Open Payments database as having received $2,548,209 across 146 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $114,436,262 across 29 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $57,294 | 5 | |
| 2024 | General | $159,710 | 21 | |
| 2023 | General | $344,591 | 39 | |
| 2022 | General | $406,596 | 24 | |
| 2021 | General | $887,140 | 23 | |
| 2020 | General | $368,112 | 17 | |
| 2019 | General | $324,765 | 17 | |
| 2025 | Ownership | $3,136,428 | 6 | |
| 2024 | Ownership | $791,900 | 1 | |
| 2023 | Ownership | $1,683,478 | 9 | |
| 2022 | Ownership | $2,152,398 | 4 | |
| 2021 | Ownership | $2,555,603 | 3 | |
| 2020 | Ownership | $2,827,895 | 3 | |
| 2019 | Ownership | $101,288,560 | 3 |
Beside peers
- Frederic Moll
- General Practice median
- Middle half of General Practice
- National median
In program year 2025, general payments to Frederic Moll were reported at $57,294. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.
Show as a table
| Year | Frederic Moll | General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $324,765 | $107 | $37–$285 | $163 |
| 2020 | $368,112 | $75 | $25–$213 | $114 |
| 2021 | $887,140 | $93 | $30–$272 | $132 |
| 2022 | $406,596 | $103 | $36–$279 | $149 |
| 2023 | $344,591 | $106 | $34–$276 | $160 |
| 2024 | $159,710 | $114 | $39–$290 | $164 |
| 2025 | $57,294 | $106 | $35–$292 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
146 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other General Practice in California
Related records
General Practice in California
Practitioners in the same specialty and state, ranked by reported value.
All General Practice
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.